Genpact (G) Cash & Equivalents (2009 - 2026)

Genpact's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $578.1 million for Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 2.93% year-over-year to $578.1 million in Q1 2026; TTM through Mar 2026 was $578.1 million, a 2.93% increase from a year earlier, with the FY2025 full-year figure at $853.8 million, up 31.71% from the prior year.
• Cash & Equivalents fell to $578.1 million in Q1 2026 per G's latest filing, from $853.8 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $1.0 billion in Q3 2024 and bottomed at $460.4 million in Q2 2022.
• The 5-year median for Cash & Equivalents is $583.7 million (2023), against an average of $653.9 million.
• Across the five-year window, Cash & Equivalents plunged 43.77% in 2022 and surged 89.03% in 2024, its largest moves.
• Year by year, Cash & Equivalents stood at $646.8 million in 2022, then retreated by 9.76% to $583.7 million in 2023, then grew by 11.06% to $648.2 million in 2024, then jumped by 31.71% to $853.8 million in 2025, then plunged by 32.3% to $578.1 million in 2026.
• Per Business Quant, the three latest G Cash & Equivalents figures stand at $578.1 million (Q1 2026), $853.8 million (Q4 2025), and $740.8 million (Q3 2025).